SG Americas Securities’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11,146
Closed -$116K 3633
2025
Q4
$116K Sell
11,146
-49,869
-82% -$500K ﹤0.01% 3169
2025
Q3
$549K Sell
61,015
-5,585
-8% -$49K ﹤0.01% 2035
2025
Q2
$866K Buy
66,600
+30,333
+84% +$456K ﹤0.01% 1270
2025
Q1
$916K Buy
+36,267
New +$1.08M ﹤0.01% 1245
2024
Q4
Sell
-5,880
Closed -$291K 3550
2024
Q3
$291K Sell
5,880
-56,518
-91% -$2.9M ﹤0.01% 2176
2024
Q2
$3.75M Buy
+62,398
New +$3.57M 0.02% 681
2024
Q1
Sell
-8,297
Closed -$335K 3379
2023
Q4
$335K Sell
8,297
-1,673
-17% -$49.1K ﹤0.01% 1739
2023
Q3
$278K Buy
9,970
+4,873
+96% +$145K ﹤0.01% 2118
2023
Q2
$147K Sell
5,097
-4,402
-46% -$97.9K ﹤0.01% 1927
2023
Q1
$158K Buy
+9,499
New +$134K ﹤0.01% 2600

Other funds holding RXST

SG Americas Securities's RXST Position: Q1 2026 in Review

SG Americas Securities sold out of RxSight (RXST) in Q1 2026, closing a stake of 11,146 shares — an estimated $116K sold.

SG Americas Securities first reported a position in RXST in Q1 2023 and held it in 10 quarters. The position peaked at $3.75M in Q2 2024. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • SG Americas Securities reported no remaining RxSight position as of Q1 2026 after selling out during the quarter.
  • SG Americas Securities sold 11,146 RxSight shares in Q1 2026, an estimated $116K.
  • SG Americas Securities first reported a position in RxSight in Q1 2023 and held it in 10 quarters.
  • SG Americas Securities's RxSight position peaked at $3.75M in Q2 2024.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.